<!-- NM_NEWSLETTERTEMPLATE|Closing Bell Newsletter --><!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html xmlns="http://www.w3.org/1999/xhtml" xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office"><head>
    <!-- NM_HTMLTEMPLATE|Responsive Subject Line --><!-- NM_COMPATIBILITY|Subject Line@New The Week Newsletter;Subject Line@New Mens Fitness Newsletter;Subject Line@New Expert Reviews Newsletter;Subject Line@New IT PRO Newsletter;Subject line@Branded Newsletter;Subject line@1 Octane Newsletter;Subject line@1 CarBuyer Newsletter;Subject line@1 Cloud Pro Newsletter;Subject line@1 Womens Fitness Newsletter;Subject line@1 Channel Pro Newsletter;Subject line@1 Den of Geek US Newsletter;Subject line@1 Coach Newsletter;Subject line@Cyclist Newsletter;Subject line@1 Auto Express Newsletter;Subject line@1 KYM Newsletter;Subject line@1 Evo Newsletter;Subject line@Whitepapers Newsletter;Subject line@Alphr Newsletter;Subject line@Kiplinger Newsletter;Subject line@Closing Bell Newsletter --><!-- NM_TITLE|Title field|Subject Line --><!-- NM_TEXTVAR|Subject Line|#||7|1 --><title>Biogen&#8217;s Pricy New Alzheimer&#8217;s Drug</title><!-- NM_SINGLEFRAME|Subject line|Responsive Subject line -->
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0">
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <!--[if !mso]><!-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <!--<![endif]-->
    <link href="https://fonts.googleapis.com/css?family=Roboto:400,700" rel="stylesheet" type="text/css">      

    <style type="text/css">    
        .ReadMsgBody { width: 100%; background-color: #e7e7e7; }
        .ExternalClass { width: 100%; background-color: #e7e7e7; }
        body { width: 100%; background-color: #e7e7e7; margin: 0; padding: 0; -webkit-font-smoothing: antialiased; font-family: Roboto, Helvetica, sans-serif }
        table { border-collapse: collapse !important; mso-table-lspace: 0pt; mso-table-rspace: 0pt; }
        *[class*="mobileOn"] { display: none !important; max-height: none !important; }
        
        @-ms-viewport{ width: device-width; }
        
        @media only screen and (max-width: 639px){
        .wrapper{ width:100%;  padding: 0 !important; }
        }    
        @media only screen and (max-width: 480px){ 
        .centerClass{ margin:0 auto !important; } 
        .imgClass{width:100% !important; height:auto;}    
        .container{ width:320px;  padding: 0 !important; }
        .header{ width:300px;  padding: 0 !important; }
        .mobile{ width:320px; display:block; padding: 0 !important; }
        .mobile50{ width:320px; padding: 0 !important; text-align:center; }
        .mobile-ad{ width:320px; display:block; padding: 0 !important; text-align:left; }
        .mobile-ad img{ height:90px; }
        *[class="mobileOff"] { width: 0px !important; display: none !important; }
        *[class*="mobileOn"] { display: block !important; max-height: none !important; }
        }    
    </style>
    
    <!--[if gte mso 9]><xml>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
  <o:PixelsPerInch>96</o:PixelsPerInch>
 </o:OfficeDocumentSettings>
</xml><![endif]-->

<!--[if gt mso 15]>
<style type="text/css" media="all">
/* Outlook 2016 Height Fix */
table, tr, td {border-collapse: collapse;}
tr { font-size:0px; line-height:0px; border-collapse: collapse; }
</style>
<![endif]-->

</head>
<body bgcolor="#e7e7e7" marginwidth="0" marginheight="0" leftmargin="0" topmargin="0" yahoo="fix" style="background-color:#e7e7e7; font-family:Roboto,Helvetica,sans-serif;margin:0;padding:0;min-width: 100%; -webkit-text-size-adjust:none;-ms-text-size-adjust:none;">
<div style="display:none;font-size:1px;color:#333333;line-height:1px;max-height:0px;max-width:0px;opacity:0;overflow:hidden;">
<!-- NM_HTMLTEMPLATE|Kiplinger Hidden Preheader --><!-- NM_COMPATIBILITY|Hidden Prehead@Kiplinger Newsletter;Hidden Prehead@Closing Bell Newsletter;Hidden Prehead@Kiplinger Special Report Newsletter --><!-- NM_TITLE|Title field|Hidden Preheader --><!-- NM_TEXTVAR|Hidden Preheader|Plus: Why You Need Umbrella Insurance||0|37 -->Plus: Microsoft Moves Further Into the Cloud(s)<!-- NM_SINGLEFRAME|Hidden Prehead|Kiplinger Hidden Preheader -->
</div>
    <!-- Start Background -->
    <table width="100%" cellpadding="0" cellspacing="0" border="0">
        <tbody><tr>
            <td width="100%" valign="top" align="center">

            <!-- NM_HTMLTEMPLATE|A Step Ahead Preheader -->
<!-- NM_COMPATIBILITY|Prehead@Closing Bell Newsletter -->
<!-- NM_TITLE|Title field|Preheader date -->

<!-- Start header 1  -->
<table width="600" cellpadding="10" cellspacing="0" border="0" class="wrapper" bgcolor="#e7e7e7">
                <tbody><tr>
        <td align="left" style="color:#666666;font-size:12px;line-height:140%"><!-- NM_TEXTVAR|Preheader message|You are receiving this limited-time email resource as a subscriber to Kiplinger's free e-newsletters. We will continue to publish this throughout the height of the coronavirus outbreak. To unsubscribe at any time, simply click the link in the footer below.||0|262 -->You are receiving this limited-time email resource as a subscriber to Kiplinger's free e-newsletters. To unsubscribe at any time, simply click the link in the footer below.
    </td></tr>
    <tr>
        <td align="center">
                  
            <!-- Start Container  -->
            <table width="580" cellpadding="0" cellspacing="0" border="0" class="header">

<tbody><tr>
                    <td width="300" align="left" style="color: #666666; font-size:12px; line-height:140%;">
                        <!-- NM_TEXTVAR|Preheader date|JANUARY 16, 2020||0|16 -->JUNE 23, 2021
					</td>
                    <td width="280" align="right" style="font-size:12px; line-height:140%;">
                        <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=yJTVdGL7Ffol_VejYtBotMaRr8W8ps4DFcGm3fEizm-DDFsDL-v70hPoZ5Zral1MnSOnLwS61XeyJ-Gk2rA5NQ~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#666666; text-decoration:underline;">View in browser</a>
                    </td>
                </tr>
            </tbody></table>
            <!-- Start Container  -->                                   
        </td>
    </tr>
                        
</tbody></table> 
<!-- End header 1  --> <!-- NM_SINGLEFRAME|Prehead|Closing Bell Preheader -->
            <!-- NM_HTMLTEMPLATE|A Step Ahead Header -->
<!-- NM_COMPATIBILITY|Header@Closing Bell Newsletter -->
<!-- NM_TITLE|Title field|Strapline -->

<!-- Start header 2  -->
<table width="600" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#FFFFFF">
    <tbody><tr>
        <td align="center">
            <!-- Start Container  -->
            <table width="510" cellpadding="0" cellspacing="0" border="0" bgcolor="#FFFFFF" class="container">
                <tbody><tr>
                    <td height="45" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr>
                <tr>
                    <td width="510" align="middle" style="font-size:14px; line-height:140%;">
                        <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=kfntpAsfX3XpDmtKrmY3lU3m5hkGeKFIDxNmC-qyrWvowZRzNH-y6PS8oJ-bdmdB4rWHDPXQUezRH7BQwEh3lw~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~"><!-- NM_URLVAR|A Step Ahead Logo|https://mediacloud.kiplinger.com/image/private/s--BGJ62oDc--/v1599247614/email/a_step_ahead_logo2.png||22|100 --><img width="400" src="https://mediacloud.kiplinger.com/image/private/s--BGJ62oDc--/v1599247614/email/a_step_ahead_logo2.png"></a>
                    </td>
                </tr>
                <tr>
                    <td width="510" align="middle" style="color:#999999; font-family:Roboto, Helvetica, sans-serif; font-size:14px; line-height:200%;">
                        <!-- NM_TEXTVAR|Strapline|DAILY INSIGHTS FOR INVESTORS||0|28 -->HOW TO PROTECT AND GROW<br>YOUR BUSINESS AND INVESTMENTS NOW
                    </td>
                </tr>
                <tr>
                    <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr>
            </tbody></table>
            <!-- Start Container  -->                   
        </td>
    </tr>                       
</tbody></table> 
<!-- End header 2 -->
<!-- NM_SINGLEFRAME|Header|Closing Bell Header --> 
            <!-- NM_FEEDTEMPLATE|Closing Bell Feed -->
<!-- NM_COMPATIBILITY|Frame 1@Closing BellNewsletter -->

<!-- NM_HTMLTEMPLATE|A Step Ahead Content -->
<!-- NM_COMPATIBILITY|Frame 1@Closing Bell Feed -->

<!-- Kiplinger 1: START -->
<table width="600" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#FFFFFF">
    <tbody><tr>
        <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
    </tr>
    <tr>
        <td align="center">                  
            <!-- Start Container  -->
            <table width="510" cellpadding="0" cellspacing="0" border="0" class="container" bgcolor="#FFFFFF">
                <tbody><tr>
                    <td height="15" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr>                 
                <tr>
					<!-- teaser -->
                    <td style="color:#666666;font-size:20px;line-height: 150%;">
						<p style="margin-bottom: 1em;margin-top: 0;"><!-- NM_HTMLFEEDITEMDESCRIPTION|Description|Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.|1|0|213 --><strong>Just how expensive is Biogen&#8217;s (<a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=vuC6-Y05y49U2QYEknwt5pG2bvgVnWRuIGudZfvQjY87NTvquGe3Dmr94eAgAZ8DKIoRPJF-DgNuaH-El4xuZw~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~">BIIB</a>) new Alzheimer&#8217;s drug aducanumab, also known as Aduhelm?</strong><strong> By the mid-2020s, it could account for 1% of national health spending and 8% of prescription drug spending, thanks to its $56,000 per patient annual price tag</strong>, according to one <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=dzCkgmqmcFlmAky8MSfD3_sl7q-s-dibRO_WgcoJ-VgqXg6wjoe8__HMvSOh5FW-UDsZi5tF_Se_x1MX7k42KA~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~">estimate</a>. Note the potentially substantial impact on spending by Medicare Part B, the portion of the federal health insurance program for senior citizens that covers drugs administered in doctors&#8217; offices and hospitals. In a scenario where 1 million patients annually use aducanumab at the current list price, Medicare Part B spending on prescription drugs could more than double from its current annual level of <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=PLfUS_8QiEubLKvcQB_AhamTokVf6qGQWaA6mc7PJWLKNWfggXkTpqmYWvYx9IbcmUqW3wdDqJ_0WeiThIb6YA~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~">$37 billion</a>.</p><p></p>
						
<!-- Kiplinger See Also START -->
<!-- NM_FEEDITEMTEMPLATE|A Step Ahead See Also -->
<!-- NM_COMPATIBILITY|See Also Frame@A Step Ahead Content -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- A Step Ahead See Also START -->
                        <table width="510" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#FFFFFF">
    <tbody><tr>
        <td height="10" style="font-size:10px; line-height:100%;"><hr></td><!-- Spacer -->
    </tr>
    <tr>
        <td align="center">                  
            <!-- Start Container  -->
            <table width="510" cellpadding="0" cellspacing="0" border="0" class="container"><tbody><tr>
        <td height="10" style="font-size:10px; line-height:100%;"></td><!-- Spacer -->
    </tr>
                <tr>
                    <td width="100%" class="mobile" align="center" style="line-height: 140%; color:#666666;font-size: 14px;letter-spacing: 1.5px;">
                       <!-- NM_TEXTCONTENT|Strap|SPONSORED CONTENT FROM SMARTASSET|1|0|33 -->SPONSORED CONTENT FROM NEW YORK LIFE
                    </td>
                </tr>                
                <tr>
                    <td height="10" style="font-size:10px; line-height:120%;"> </td><!-- Spacer -->
               </tr>
                <tr>
                    <td><!-- NM_URLVAR|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=OvpJ9VQfebxYOjDX-oq_mpez6xuMwgC1LLsKgrhi3TsopXDclGYE3VT7By2B1ISY98IoAgl_qhXnvtu1VM-1sg~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#000000; font-family: Roboto, Helvetica, sans-serif; font-size:20px; font-weight:700; text-decoration:none; line-height:1.2;"><!-- NM_TEXTCONTENT|Headline|Headline|1|0|8 -->A New Retirement Normal Deserves A New Solution to Meet It. Introducing IndexFlex.</a></td>
                </tr> 
                <tr>
                    <td height="5" style="font-size:10px; line-height:150%;"> </td><!-- Spacer -->
                </tr> 
               <tr>
                    <td style="color:#666666;font-size:20px;line-height: 140%;">
                    <p style="margin-bottom: 1em;margin-top: 0;"><!-- NM_HTMLCONTENT|Description|Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.|1|0|213 -->Empower retirement investors with a new customizable solution featuring protection they can count on. The New York Life IndexFlex Variable Annuity is designed for this moment &#8211; backed by a company built for all the moments to come. Asset protection and investment flexibility for retirement on your terms. <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=aQ4HUY7q5gBc8zjlBOqQyKKq5w_0GJJ_9poMeXu3ZPMpnaQvGDO9WVegv5EGD46i4YpEJcya_aM_HyV8OU_Y1g~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~">Learn more about this new solution.</a></p>
                    </td>
                </tr>
                <tr>
                    <td style="color:#CC2936;font-size:16px;line-height: 140%;"><!-- NM_URLVAR|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=Bfxfy7-iiYtwlFaznr_QuhOdt4TpWAwPTiP3m1aWUZeJZYo3DSM2PT7KIvNhBqvQrANs1q-LYbvLl9KPlQHatg~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#CC2936;text-decoration:none;font-weight: 700;">READ MORE</a><p></p></td>
                </tr>                
            </tbody></table>
            <!-- End Container  -->          
        </td>
    </tr>
    <tr>
        <td height="10" style="font-size:10px; line-height:150%;"></td><!-- Spacer -->
    </tr>  
    <tr>
        <td height="10" style="font-size:10px; line-height:150%;"><hr></td><!-- Spacer -->
    </tr>                     
</tbody></table> 
<!-- End A Step Ahead See Also  --><!-- NM_SINGLEFRAME|See Also Frame|Kiplinger See Also|1 -->
<!-- End Kiplinger See Also  -->

<!-- NM_HTMLTEMPLATE|Kiplinger Afterword -->
<!-- NM_COMPATIBILITY|Afterword Frame@Closing Bell Story with Image -->

<p style="margin-bottom: 1em;margin-top: 1em;">
<!-- NM_HTMLCONTENT|Afterword|Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.|1|0|213 --></p><p><strong>But this also makes aducanumab a ripe target for Washington politicians and patient advocates angry about rising prescription drug prices.</strong> The Institute for Clinical and Economic Review, a nonprofit, <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=7PfuiaVV-QzcF__NxD2l9rIrbMJSSMXnEwGTS7rI2vTtAK4xzcxwIX-yIMMalOQXcZ3GGkUTp0erI-UXfj4WWg~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~">figures</a> a justifiable price for aducanumab of only $2500 to $8300. Both the Centers for Medicare and Medicaid Services and insurers  could push back against Biogen's price, especially given the lack of clear drug effectiveness. And by setting such a high price for a drug of uncertain benefit to a vulnerable patient population, Biogen will, at the very least, need to deal with some thorny public relations issues.</p>
<p><strong>Microsoft (<a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=F2G1J-FFbdeXykWR8TWEMDzIANr_YD4aag9Q_prlpEAx5e3vcZcLnzZ7ycQ5EKj7p5bHcFvuo4_j5RfKv--X-g~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~">MSFT</a>) cleared the $2 trillion market-capitalization mark on Tuesday, but Wedbush analyst Daniel Ives believes the tech mega-cap&#8217;s ceiling is even higher.</strong> In a note released this morning, Ives reiterated his Outperform rating (equivalent of Buy) and raised his 12-month price target on Microsoft shares from $310 per share to $325, implying 22% upside over the next year. <strong>The spark? Renewed optimism over what has been Microsoft&#8217;s primary growth story for years: The cloud.</strong> In his latest June-quarter checks, Ives said his team is &#8220;seeing deal sizes continue to increase markedly&#8221; amid an acceleration of enterprise-wide shifts to <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=wO6Iuq9lqQrrYf_VHEzjZS_hOYcquvTZcehN5BoD-DhvELSN1vxUMTgiZk8T8pginETzylHSytqNcS5fU9zgMA~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~">cloud-based architecture</a>, as companies accept that their workforces will retain a heavy remote focus post-pandemic. Says Ives: &#8220;While many tech stocks overall are all being lumped together as part of the WFH trade, we believe the growth story at MSFT is not slowing down as more enterprises/governments head down this cloud path over the coming years.&#8221;</p>
<p></p>
<!-- NM_SINGLEFRAME|Afterword Frame|Kiplinger Afterword|1 -->
<p><em>Free download, <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=AzEg6Zveo_lgVREfQG7rHSG9xmjhzTgHb0UfGihrwbW9xpVTu4n61CDwyLO3gl91eWOHAhoQhOA0p391wm1P3A~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" target="_blank">The Kiplinger Letter's Forecast</a>. No information required from you.</em></p>

                    </td>
                </tr>

           </tbody></table>
            <!-- End Container  -->          
        </td>
    </tr>
    <tr>
        <td height="45" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
    </tr>                        
</tbody></table> 
<!-- End Kiplinger 1  --> 

<!-- NM_MULTIFRAME|Frame 1|Closing Bell Story with Image|1 --><!-- NM_HTMLTEMPLATE|Closing Bell Native Ad -->
<!-- NM_COMPATIBILITY|Frame 1@Closing Bell Newsletter;Frame 1@Closing Bell Feed -->
<!-- NM_TITLE|Title field|Strap -->

<!-- Widget (start) -->
<!-- Start Ad -->
<table width="600" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#FFFFFF">
    <tbody><tr>
        <td height="14" valign="middle" style="display:block; font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
    </tr>
    <tr>
        <td align="center">                  
            <!-- Start Container  -->
            <table width="510" cellpadding="0" cellspacing="0" border="0" class="container" bgcolor="#FFFFFF">
                <tbody><tr>
                    <td class="mobile" align="middle" style="line-height: 140%; color:#666666;font-size: 14px;letter-spacing: 1.5px;">
                       <!-- NM_TEXTCONTENT|Strap|SPONSORED CONTENT FROM SMARTASSET|1|0|33 -->SPONSORED CONTENT FROM NEW YORK LIFE
                    </td>
                </tr>                
                <tr>
                    <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr>                 
                <tr>
                    <td>                        
                       <!-- NM_URLVAR|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=JVegZrc82nBpVaIcSeY7w1boMAwbqUI-e_xXamjf5p2GkpDkcJThiLe5tumSNwqe1su8FfpLr3tD0lLEIArWUg~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~"><!-- NM_URLVAR|Image|https://www.kiplinger.com/kipimages/happy_beard_man_solid_background_002.jpg|1|10|76 --><img src="https://mediacloud.kiplinger.com/image/private/s--FzQEyLHE--/v1613593020/email%20ads/newyorklife/600x400_NYL_Rise.jpg" width="510" class="imgClass" style="width:100%; display:block; line-height:130%;"></a>
                    </td>
                </tr>
                <tr>
                    <td height="21" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
               <tr>
                    <td><!-- NM_URLVAR|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=yFFaIKl6QM07zBadSnZKRNSyDhzI3N5PbMnMTb3S6G2wRuiAM6rs-0M4oCaVt4afQcuY8axXfmbkTL6dV-bA9w~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#000000;text-decoration:none;font-size:30px;font-weight:700; line-height: 120%;"><!-- NM_TEXTCONTENT|Headline|Headline|1|0|8 -->A New Retirement Normal Deserves A New Solution to Meet It. Introducing IndexFlex.</a></td>
                </tr>
                <tr>
                    <td height="15" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
                <tr>
                    <td style="color:#666666;font-size:20px;line-height: 140%;">
                    <p style="margin-bottom: 1em;margin-top: 0;"><!-- NM_HTMLCONTENT|Description|Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.|1|0|213 -->Empower retirement investors with a new customizable solution featuring protection they can count on. The New York Life IndexFlex Variable Annuity is designed for this moment &#8211; backed by a company built for all the moments to come. Asset protection and investment flexibility for retirement on your terms. <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=acYra_8jhkCc3d1X2le6E7zkJL7wa4vmV6nCO33KQkQgzA032cxeEmCJ13uldpUlyMVJYi3SLFWQXZkCMLfpYA~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~">Learn more about this new solution.</a></p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <table align="center" bgcolor="#FFFFFF">
                            <tbody><tr>
                                <td align="center" bgcolor="#CC2936" valign="middle"><!-- NM_URLVAR|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=rxgOLXjEHqmUihXf86GQB-qQCWCQXnBMaM6E7z6b4FADN2trBHFXcxSDyni3MGQdJFwy1mX4GyghZrMrccnSyA~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="font-size:16px; font-family: Roboto, Helvetica, sans-serif; font-weight:700; color:#ffffff; text-decoration:none; line-height:300%; border-left:50px solid #CC2936; border-right:50px solid #CC2936; border-top:15px solid #CC2936; border-bottom:15px solid #CC2936;">READ MORE</a></td>
                            </tr>
                        </tbody></table>
                    </td>
                </tr>                  
            </tbody></table>
            <!-- End Container  -->          
        </td>
    </tr>
    <tr>
        <td height="15" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
    </tr>                        
</tbody></table> 
<!-- End Ad  -->
<!-- Widget (end) -->

<!-- NM_FEEDTEMPLATE|Kiplinger List Feed -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger Newsletter;Frame 1@Closing Bell Newsletter -->
<!-- NM_TITLE|Title field|List Title -->

<!-- latest investing news -->
<table width="600" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#FFFFFF">
    <tbody><tr>
        <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
    </tr>
    <tr>
        <td align="center">                  
            <!-- Start Container  -->
            <table width="510" cellpadding="0" cellspacing="0" border="0" class="container" bgcolor="#FFFFFF">
                <tbody><tr>
                    <td class="mobile" align="middle" style="line-height: 150%; color:#666666;font-size: 14px;letter-spacing: 1.5px;"><!-- NM_TEXTCONTENT|List Title|LATEST INVESTING NEWS FROM KIPLINGER.COM|1|0|40 -->LATEST INVESTING NEWS FROM KIPLINGER.COM</td>
                </tr>                
                <tr>
                    <td height="21" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr>

<!-- NM_FEEDITEMTEMPLATE|Kiplinger List Story -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger List Feed -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- Kiplinger More : START -->
               <tr>
                    <td><!-- NM_FEEDITEMLINK|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=v2-NqZOrMf1yj_OO3jGgycj3Y1UOSTn3dCRWXLoOdQhd9AEctGsahhL7LvcpSs1bW7kL5jtst-4L_qRRuswcBQ~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#000000;text-decoration:none;font-size:20px; font-weight:700; line-height:125%;"><!-- NM_FEEDITEMTITLE|Headline|Headline|1|0|8 -->Keep Yourself Honest With a Financial "Halftime" Audit</a>
                    </td>
                </tr>
                <tr>
                     <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
<!-- Kiplinger More : END -->

<!-- NM_FEEDITEMTEMPLATE|Kiplinger List Story -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger List Feed -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- Kiplinger More : START -->
               <tr>
                    <td><!-- NM_FEEDITEMLINK|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=Gj_88gsBFMv5-mnyaAGuQNYBT6K_31Wx8He4HWbMRkcqFXfRrkIL875i2QQ6j-ZwGHS6q22YTAFxWCEb0MrDjA~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#000000;text-decoration:none;font-size:20px; font-weight:700; line-height:125%;"><!-- NM_FEEDITEMTITLE|Headline|Headline|1|0|8 -->6 AI Stocks to Watch for Rapid Growth</a>
                    </td>
                </tr>
                <tr>
                     <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
<!-- Kiplinger More : END -->

<!-- NM_FEEDITEMTEMPLATE|Kiplinger List Story -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger List Feed -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- Kiplinger More : START -->
               <tr>
                    <td><!-- NM_FEEDITEMLINK|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=nF0BWiVt_3CzgMzbFfenG1zlY_hmzmS4cUnIAG5sfAO11RoVuzg1h6JwnkPYiKqrWOBFGvYBXLehPjeFv0GDOA~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#000000;text-decoration:none;font-size:20px; font-weight:700; line-height:125%;"><!-- NM_FEEDITEMTITLE|Headline|Headline|1|0|8 -->To Be Happy in Retirement, Don&#8217;t Be Afraid to Use Your &#8216;Nuts&#8217;</a>
                    </td>
                </tr>
                <tr>
                     <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
<!-- Kiplinger More : END -->

<!-- NM_FEEDITEMTEMPLATE|Kiplinger List Story -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger List Feed -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- Kiplinger More : START -->
               <tr>
                    <td><!-- NM_FEEDITEMLINK|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=nMUwMl6YBFIM0QD1zUl67SqDtwhDXoWV3ufj8hr0EYXIwctoHWEkEMe_4N54p_HwCJeUv828VT_Br7BkSEle8w~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#000000;text-decoration:none;font-size:20px; font-weight:700; line-height:125%;"><!-- NM_FEEDITEMTITLE|Headline|Headline|1|0|8 -->SSDI and COVID-19: How to Apply for Disability Benefits Now</a>
                    </td>
                </tr>
                <tr>
                     <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
<!-- Kiplinger More : END -->

<!-- NM_FEEDITEMTEMPLATE|Kiplinger List Story -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger List Feed -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- Kiplinger More : START -->
               <tr>
                    <td><!-- NM_FEEDITEMLINK|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=3Xo3TTjuzQjQGWagVJSeN37oD_yx_0pC-cvso69r5kfzUzKYRESGaD_8qaYMh8UePWtsp8YIgB56C-qw5jFRzg~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#000000;text-decoration:none;font-size:20px; font-weight:700; line-height:125%;"><!-- NM_FEEDITEMTITLE|Headline|Headline|1|0|8 -->Sign Up Free for Kiplinger's Retirement E-Newsletter to Plan for and Make the Most of a Richly Rewarding Retirement</a>
                    </td>
                </tr>
                <tr>
                     <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
<!-- Kiplinger More : END -->

<!-- NM_MULTIFRAME|Frame 1|Kiplinger List Story|5 -->


            </tbody></table>
            <!-- End Container  -->          
        </td>
    </tr>
    <tr>
		<td height="45" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
	</tr>                        
</tbody></table> 
<!-- End latest investing news  --><!-- NM_MULTIFRAME|Frame 1|Closing Bell Feed|1 -->
	    <!-- NM_HTMLTEMPLATE|A Step Ahead Footer (Coronavirus) -->
<!-- NM_COMPATIBILITY|Footer@Closing Bell Newsletter -->

<!-- Footer -->
<table width="600" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#e7e7e7">
    <tbody><tr style="border-collapse: collapse;">
        <td bgcolor="#e7e7e7" height="30" style="font-size:10px; line-height:130%; border-collapse:collapse;"> </td><!-- Spacer -->
    </tr>                     
    <tr style="border-collapse: collapse;">
        <td align="center">                  
            <!-- Start Container  -->
            <table border="0" cellpadding="0" cellspacing="0" width="95%" bgcolor="#e7e7e7" class="container" style="border-collapse: collapse;">
				<tbody>
                    <tr>
                        <td bgcolor="#e7e7e7" align="center" style="border-collapse:collapse; color:#fff; font-size:20px; font-family: Roboto, Helvetica, Arial, sans-serif;"><img src="https://mediacloud.kiplinger.com/image/private/s--Y2F2iy-y--/v1590676042/email/cb_kiplinger_999999.png" width="200" height="63" style="display:block;" alt="Kiplinger" title="Kiplinger"></td>
                    </tr>
                    <tr>
                        <td bgcolor="#e7e7e7" height="20" style="border-collapse:collapse; font-size:10px; line-height:120%;"> </td><!-- Spacer -->
                    </tr> 
                    <tr>
                        <td bgcolor="#e7e7e7" align="center" style="border-collapse:collapse;">
                        <table border="0" cellpadding="0" cellspacing="0" width="70%" bgcolor="#e7e7e7" class="container" style="border-collapse: collapse;">
							<tbody>
                                <tr>
                                    <td width="30%"></td>
                                    <td align="center" width="10%" style="border-collapse:collapse; color:#fff;"><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=JmOPbxIsesE-PFqUiwRkVuAYj_3uAjaxyHoBWJJrqIqpa4ZIGl67az1O7IMXz4BElNAJy6ojb-ADIzKcVxEUKQ~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#cc2936; text-decoration:none;">
                                    <img src="https://mediacloud.kiplinger.com/image/private/s--VgMkLGEV--/v1590676042/email/cb_fb_100.png" width="25" height="26" alt="Facebook" title="Facebook" style="border-collapse:collapse; color:#fff;display:block;"></a></td>
                                    <td width="4%"></td>
                                    <td align="center" width="10%" style="border-collapse:collapse; color:#fff;"><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=wWppyVP7I9TwHoIdeyCC7Y5iloCWgyoSoIJXZRI6_nsbzGFhrTHtnVaycGF0K8o6mZLAgvJclTDKzKkqTEzlfg~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#cc2936; text-decoration:none;">
                                    <img src="https://mediacloud.kiplinger.com/image/private/s--3BiG3O86--/v1590676041/email/cb_tw_100.png" width="25" height="26" alt="Twitter" title="Twitter" style="border-collapse:collapse; color:#fff;display:block;"></a></td>
                                    <td width="6%"></td>
                                    <td align="center" width="10%" style="color:#fff;"><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=FHvrTK2l8xu2RBVGPidLT5Nsa8fMZFi-LsYdLpKbhtyaRyEuhbzZy8HBNtUv9O0HhclnRLYpsGl5tue3RWI2rA~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="border-collapse:collapse; color:#cc2936; text-decoration:none;">
                                    <img src="https://mediacloud.kiplinger.com/image/private/s--ii3iyun6--/v1590676041/email/cb_li_100.png" width="25" height="26" alt="LinkedIn" title="LinkedIn" style="border-collapse:collapse; color:#fff;display:block;"></a></td>                                    
                                    <td width="30%"></td>
                                </tr>
                            </tbody>
                        </table>
                        </td>
                    </tr>

                    <tr>
                        <td bgcolor="#e7e7e7" height="20" style="border-collapse:collapse; font-size:10px; line-height:120%;"> </td><!-- Spacer -->
                    </tr> 
                    <tr>
                        <td bgcolor="#e7e7e7" align="center" style="border-collapse:collapse; color:#666666; font-size:15px; font-family: Roboto, Arial, Helvetica, sans-serif; line-height:120%;">Send this to a friend. <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=UWE4a8AZ5Q6olfivDhFk3ls5yHBSOx9HJKt__AufoCi89uD8P7r_7EhQC5cTtl9o7nr4RS1rBU_jKxw5dW2jIQ~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#666666; text-decoration:underline">Click here.</a></td>
                    </tr>
                    <tr>
                        <td bgcolor="#e7e7e7" height="20" style="border-collapse:collapse; font-size:10px; line-height:120%;"> </td><!-- Spacer --> 
                    </tr> 
                    <tr>
                        <td bgcolor="#e7e7e7" style="border-collapse:collapse; color:#666666; font-size:12px; line-height:120%; font-family: Roboto, Helvetica, Arial, sans-serif;" align="center">
                        All content ©2021 The Kiplinger Washington Editors<br>
                        1100 13th Street, NW, Suite 1000<br>
                        Washington, D.C. 20005<br><br>
Thank you for subscribing to Kiplinger's A Step Ahead, a free resource to help readers navigate the economic recovery from COVID-19. If you ever wish to stop receiving this service, please <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=B4pkMflgDwcLvqdg52hC3gQUoJP_Ins6jGhalBe0uXPbpvyO2fRRlazLDsOtzyojej46ki1BHs10GkAPHR4xVQ~~&amp;t=1a3Gr5uOQcUMRDIBlA-HqA~~" style="color:#666666; text-decoration:underline"> </a>.
                        </td>
                    </tr> 
                    <tr>
                        <td bgcolor="#e7e7e7" height="30" style="border-collapse:collapse; font-size:10px; line-height:120%;"> </td><!-- Spacer --> 
                    </tr> 
                                                   
                </tbody>
            </table>     
            <!-- End Container  -->          
        </td>
    </tr>                     
</tbody></table> 
<!-- End footer  --> 

<!-- NM_SINGLEFRAME|Footer|Closing Bell Footer -->

            </td>
        </tr>
    </tbody></table>
    <!-- End Background -->
    

<table cellpadding="0" cellspacing="0" width="100%" style="border-collapse: collapse"><tbody><tr><td><img height="1" style="display: block" width="1" border="0" src="https://alertskiplinger.mmsend.com/spacer.cfm?tracking_id=51346708388&amp;jid=52112186"></td></tr></tbody></table></body></html>
